Concepedia

Thomas G Martin

TG

13

Publications

724

Citations

11

H-Index

2010

Active since

Affiliations

University of California, San Francisco(Current)

Emory University

Centro de Investigación del Cáncer

Amsterdam University Medical Centers

Centro de Investigación Biomédica en Red de Cáncer

Thomas G Martin is an author at University of California, San Francisco specializing in medicine, health sciences, and oncology.

ORCID

Top concepts

Publications per year

2010–2024

13

Publications

13

Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies

David Siegel, Thomas G Martin, A. Nooka et al. · Haematologica · 2013 · 338 citations · Full text

, , +16

Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC‐1 study

Ajay K. Nooka, Cesar Rodriguez, María‐Victoria Mateos et al. · Cancer · 2023 · 67 citations · Full text

Long-term follow-up from the phase 1/2 MajesTEC-1 trial of teclistamab in patients with relapsed/refractory multiple myeloma.

Alfred L. Garfall, Ajay K. Nooka, Niels W.C.J. van de Donk et al. · Journal of Clinical Oncology · 2024 · 57 citations

, , +17

Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC‐1 study of patients with relapsed/refractory multiple myeloma

Thomas G Martin, María‐Victoria Mateos, Ajay K. Nooka et al. · Cancer · 2023 · 54 citations · Full text

Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I Study

Jonathan L. Kaufman, Roberto Mina, Andrzej Jakubowiak et al. · Blood Cancer Journal · 2019 · 51 citations · Full text

Rows per page

1–5 of 13